AI Article Synopsis
- Clinical trials are crucial for advancing treatments for substance use disorders (SUD), but the SARS-CoV-2 pandemic disrupted an ongoing smoking cessation trial.
- To adapt, the trial shifted to remote support through phone and video sessions to ensure participants received counseling and monitoring.
- The experience highlights the need to evaluate the effects of these changes on participant experiences and treatment results in future clinical trials.
Article Abstract
Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403863 | PMC |
| http://dx.doi.org/10.1016/j.jsat.2020.108100 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!